EXHIBIT 99.1

FOR:            HEALTHCARE TECHNOLOGIES LTD.

CONTACT:        Eran Rotem CFO
                +972-3-9277232/3

PRNEWSWIRE      Mrs. Rakefet Sudri PR Newswire Israel
CONTACT:        info@prnewswire.co.il
                DL  +972-77-2005042
                F   +972-77-2005043
                M   +972-52-4308081

        HEALTHCARE TECHNOLOGIES LTD. (NASDAQ: HCTL) ANNOUNCES RECEIPT OF
                             NASDAQ DELISTING NOTICE

New York, NY, January 10, 2008 - Healthcare Technologies Ltd., (the "Company")
today announced that it received a letter dated January 7, 2008 from the Staff
of the Listing Qualifications Department (the "Staff Determination") of The
NASDAQ Stock Market LLC, which indicated that because the Staff believes that
the Company's Plan of Arrangement with NexGen Biofuels, Inc., which closed on
December 31, 2007, constituted a reverse merger, the surviving entity is
required to submit an initial listing application and satisfy Nasdaq's initial
listing standards. On September 7, 2007, NexGen Biofuels, Ltd. submitted its
listing application. However, the application was not approved because, among
other things, the Company did not meet the minimum $4 bid price requirement for
initial listing. Accordingly, the Company's securities will be delisted from The
NASDAQ Stock Market. In that regard, unless the Company requests an appeal of
this determination, NASDAQ will suspend trading of the Company's securities on
the Capital Market at the opening of business on January 16, 2008.

In response, the Company intends to timely request a hearing before a NASDAQ
Listing Qualifications Panel to address the Staff Determination and seek
continued listing in accordance with applicable NASDAQ rules. The Company's
hearing request will stay any delisting action pending the issuance of a
decision by the Panel following the hearing.

In the event that the Company's appeal is unsuccessful, the Company believes
that its ordinary shares will be eligible for trading on the OTC Bulletin Board,
subject to the filing of a Form 211 by a market maker.

For more information on NexGen Biofuels, visit www.nexgenbiofuels.net





SAFE HARBOR: THIS PRESS RELEASE CONTAINS CERTAIN FORWARD LOOKING STATEMENTS
WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933 AND SECTION 21E
OF THE SECURITIES EXCHANGE ACT OF 1934. WITH THE EXCEPTION OF HISTORICAL
INFORMATION CONTAINED HEREIN, THE MATTERS DISCUSSED IN THIS PRESS RELEASE
INVOLVE RISK AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER MATERIALLY FROM
THOSE EXPRESSED IN ANY FORWARD LOOKING STATEMENT MADE BY OR ON BEHALF OF
HEALTHCARE TECHNOLOGIES LTD. READERS ARE REFERRED TO THE DOCUMENTS FILED BY THE
COMPANY WITH THE SECURITIES AND EXCHANGE COMMISSION, SPECIFICALLY THE FORM 8-K
FILED ON JANUARY 7, 2008 THAT IDENTIFIES IMPORTANT RISKS WHICH COULD CAUSE
ACTUAL RESULTS TO DIFFER FROM THOSE CONTAINED IN THE FORWARD LOOKING STATEMENTS.